News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,523 Results
Type
Article (87664)
Company Profile (824)
Press Release (777020)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233153)
Career Advice (4142)
Deals (39827)
Drug Delivery (143)
Drug Development (91323)
Employer Resources (203)
FDA (18328)
Job Trends (17412)
News (397618)
Policy (39939)
Tag
Academia (3006)
Academic (2)
Accelerated approval (22)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (157)
Alzheimer's disease (1730)
Antibody-drug conjugate (ADC) (285)
Approvals (18404)
Artificial intelligence (558)
Autoimmune disease (122)
Automation (32)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (180)
Biotechnology (487)
Bladder cancer (143)
Brain cancer (57)
Breast cancer (555)
Cancer (4425)
Cardiovascular disease (396)
Career advice (3564)
Career pathing (39)
CAR-T (267)
CDC (57)
Cell therapy (736)
Cervical cancer (34)
Clinical research (76181)
Collaboration (1528)
Company closure (4)
Compensation (1014)
Complete response letters (64)
COVID-19 (2969)
CRISPR (92)
C-suite (687)
Cystic fibrosis (145)
Data (5384)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (483)
Diagnostics (7140)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (261)
Drug pricing (203)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99851)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (134164)
Executive appointments (1005)
FDA (21056)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1384)
Gene editing (198)
Generative AI (56)
Gene therapy (599)
GLP-1 (1071)
Government (5409)
Grass and pollen (8)
Guidances (378)
Healthcare (20941)
HIV (54)
Huntington's disease (43)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (27)
Indications (68)
Infectious disease (3234)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (207)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (628)
Lymphoma (311)
Machine learning (35)
Management (66)
Manufacturing (710)
MASH (164)
Medical device (14947)
Medtech (14985)
Mergers & acquisitions (22842)
Metabolic disorders (1256)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (284)
Neuropsychiatric disorders (78)
Neuroscience (2877)
NextGen: Class of 2025 (7703)
Non-profit (5099)
Now hiring (60)
Obesity (598)
Opinion (322)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (191)
Parkinson's disease (261)
Partnered (33)
Patents (448)
Patient recruitment (367)
Peanut (58)
People (66516)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23497)
Phase II (33061)
Phase III (24928)
Pipeline (3520)
Policy (314)
Postmarket research (3554)
Preclinical (10623)
Press Release (72)
Prostate cancer (221)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (740)
Real estate (7432)
Recruiting (80)
Regulatory (28359)
Reports (65)
Research institute (2709)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (81)
Schizophrenia (144)
Series A (223)
Series B (169)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (43)
Startups (4322)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1081)
Venture capital (74)
Weight loss (421)
Women's health (72)
Worklife (21)
Date
Today (53)
Last 7 days (379)
Last 30 days (3264)
Last 365 days (33351)
2025 (31059)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (319)
Arkansas (14)
Asia (51192)
Australia (9002)
California (10501)
Canada (3092)
China (998)
Colorado (442)
Connecticut (474)
Delaware (303)
Europe (117762)
Florida (1535)
Georgia (340)
Hawaii (3)
Idaho (68)
Illinois (863)
India (60)
Indiana (506)
Iowa (21)
Japan (355)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1377)
Massachusetts (7797)
Michigan (332)
Minnesota (611)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (115)
New Hampshire (81)
New Jersey (2881)
New Mexico (32)
New York (2817)
North Carolina (1504)
North Dakota (10)
Northern California (4904)
Ohio (320)
Oklahoma (22)
Oregon (51)
Pennsylvania (2151)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (58)
South Dakota (1)
Southern California (4031)
Tennessee (162)
Texas (1642)
United States (38303)
Utah (316)
Vermont (1)
Virginia (268)
Washington D.C. (85)
Washington State (879)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,523 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
December 1, 2025
·
13 min read
Press Releases
Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds
December 1, 2025
·
4 min read
Press Releases
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
Recognition of BioMark Leadership in Early Cancer Detection Validates Commercialization Trajectory of Multimodal Lung Cancer Screening Platform
December 1, 2025
·
4 min read
Events
Advanced Therapies Week
Advanced Therapies Week 2026 takes place February 9–12 in San Diego, uniting more than 2,000 leaders from biotech, investment, science, manufacturing, and regulation to turn innovation into action. For the first time on the West Coast, the event will be held in a premium new venue at the heart of one of the fastest-growing biotech hubs in the US. Attendees can expect five content tracks, 250+ speakers, 3,000+ 1:1 meetings, and 200+ exhibitors, alongside the standout Investment Summit. In 2026, networking takes center stage, with a brand-new Networking Concierge service, an upgraded human-led matchmaking event app, and an expanded line-up of social experiences from Topgolf to a Petco Park takeover and Sip & Connect official welcome party, plus dedicated networking zones integrated throughout the show floor. For more information, and tickets, visit www.phacilitate.com/advanced-therapies-week.
December 1, 2025
Press Releases
Biolexis Therapeutics VP of Clinical Development Selected for Dual Featured Presentations at the 2nd Innovation in Obesity Therapeutics Summit
December 1, 2025
·
1 min read
Press Releases
Cancer Immunotherapy Market Size to Hit USD 700.09 Billion by 2034, Growing at a Stellar 11.95% CAGR
December 1, 2025
·
1 min read
Press Releases
Plasmid DNA Manufacturing Market Poised to Surge to USD 18.11 Billion by 2034 at a Remarkable 21.05% CAGR
December 1, 2025
·
1 min read
Press Releases
Digital Transformation in Life Sciences Market: The New Era of AI-Powered Drug Discovery and Virtual Clinical Innovation
December 1, 2025
·
1 min read
Press Releases
Pancreatic Cancer Diagnostic Market Size to Reach USD 9.76 Billion by 2034, Growing at a Stellar 13.8% CAGR
December 1, 2025
·
1 min read
Press Releases
Respiratory Syncytial Virus Vaccines Market Size to Hit USD 120.86 Billion by 2034
December 1, 2025
·
1 min read
1 of 86,553
Next
